Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 70.20
+0.30 (0.43%)
Nov 6, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 11.76 billion as of November 6, 2026. It is the 16,591st most valuable company in the world and the 587th biggest in Taiwan. Its market cap has decreased by 65.45% in one year.
Market Cap
11.76B
Enterprise Value
11.14B
Revenue
34.37M
Global Rank
Country Rank
#587 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 11.76B, an increase of 173.75%. That is a compound annual growth rate of 9.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 11.76B | -64.12% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 16.11B |
| Medigen Vaccine Biologics | 15.42B |
| Steminent Biotherapeutics | 15.19B |
| TaiMed Biologics | 15.03B |
| Ever Supreme Bio Technology | 14.56B |
| EirGenix | 14.01B |
| Gongwin Biopharm Holdings | 12.17B |
| ACRO Biomedical | 11.51B |